Articles from Caixin Global, Caixin Global

Caixin Global

Articles from Caixin Global

Caixin is a media group dedicated to providing financial and business news through periodicals, online content, mobile apps, conferences, books and TV/video programs. Caixin aims to blaze a trail that helps traditional media prosper in the new media age through integrated multimedia platforms.

News from Caixin

Cross Asset Strategy

<ul><li>Drug / State drugmaker snared over scheme to rip off government</li><li>Housing / China offers multiple-child families housing help as demographic crisis looms</li><li>Economy / China’s Li urges more pro-growth policy as economy sputters</li></ul>

Drug / State drugmaker snared over scheme to rip off governmentHousing / China offers multiple-child families housing help as demographic crisis loomsEconomy / China’s Li urges more pro-growth policy as economy sputters

CX Daily: State Drugmaker Snared Over Scheme to Rip Off Government

China

Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. manufactures and sells Chinese patent medicine. The Company also wholesales, retails, imports, and exports Western and Chinese pharmaceutical products and various medical apparatus.

Guangzhou Baiyunshan Pharmaceu (600332 CH)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

CX Daily: State Drugmaker Snared Over Scheme to Rip Off Government

State drugmaker snared over scheme to rip off government. China offers multiple-child families housing help as demographic crisis looms

Caixin Global